Syngene International

Syngene International EBIT Margin

The EBIT Margin (Operating Margin) of Syngene International (SYNGENE.NS) as of Oct 31, 2026 is 14.08 %. In the previous year, EBIT Margin (Operating Margin) was 19.58 % — a change of -28.06% (lower).

EBIT Margin

14.08 %

YoY

-28.06%

Last updated:

EBIT Margin (Operating Margin) of Syngene International is 2026 14.08 % . EBIT Margin (Operating Margin) of Syngene International was 2025 19.58 % . It decreases by -28.06% lower compared to the previous year.

For Syngene International, the operating (EBIT) margin of 14.1% is down versus 36.7% a few years ago.

The Syngene International EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
38.11 INR
Jan 1, 2020
38.79 INR
Jan 1, 2021
38.46 INR
Jan 1, 2022
36.74 INR
Jan 1, 2023
20.01 INR
Jan 1, 2024
19.15 INR
Jan 1, 2025
19.58 INR
Jan 1, 2026
14.08 INR
The Syngene International EBIT Margin history
YEAREBIT MarginYoY
14.08 %-28.06%
19.58 %+2.23%
19.15 %-4.29%
20.01 %-45.55%
36.74 %-4.46%
38.46 %-0.86%
38.79 %+1.77%
38.11 %-1.94%
38.87 %-6.30%
41.48 %-6.56%
44.39 %+1.98%
43.53 %0.00%
43.53 %+16,032.46%
0.27 %+18.26%
0.23 %+35.77%
0.17 %+4.10%
0.16 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syngene International Stock analysis

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngene International stock

EBIT Margin (Operating Margin) of Syngene International is 14.08 % in 2026.

EBIT Margin (Operating Margin) of Syngene International changed from 19.58 % to 14.08 %, representing a -28.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Syngene International since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Syngene International with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Syngene International

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Syngene International